Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Muthu Veeraputhiran

Concepts (110)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
9
2023
567
2.040
Why?
Hematologic Neoplasms
2
2021
99
0.810
Why?
Blood Platelets
3
2011
249
0.710
Why?
Transplantation Conditioning
2
2017
84
0.680
Why?
Hematopoietic Stem Cells
2
2011
184
0.670
Why?
Comorbidity
1
2017
613
0.500
Why?
Leukocytes
2
2011
67
0.470
Why?
Melphalan
1
2015
174
0.470
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2014
56
0.470
Why?
Granulocyte Colony-Stimulating Factor
1
2014
61
0.460
Why?
Hematopoietic Stem Cell Mobilization
1
2014
57
0.460
Why?
Cyclophosphamide
1
2014
166
0.440
Why?
Hemagglutination Tests
1
2011
7
0.400
Why?
Aldehyde Dehydrogenase
1
2011
26
0.390
Why?
Graft vs Host Disease
2
2023
75
0.390
Why?
Isoantibodies
1
2011
25
0.390
Why?
Transplantation, Autologous
4
2015
469
0.370
Why?
Plateletpheresis
1
2010
7
0.370
Why?
Blood Preservation
1
2010
26
0.370
Why?
Cryopreservation
1
2010
31
0.360
Why?
Blood Proteins
1
2010
82
0.360
Why?
Anaphylaxis
1
2010
71
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
990
0.330
Why?
Rhabdomyolysis
1
2008
12
0.310
Why?
Simvastatin
1
2008
29
0.310
Why?
Anticholesteremic Agents
1
2008
28
0.310
Why?
Quinazolines
1
2008
33
0.310
Why?
Multiple Myeloma
2
2015
2954
0.310
Why?
Protein Kinase Inhibitors
1
2008
206
0.270
Why?
Pyrazoles
2
2023
114
0.250
Why?
Time Factors
1
2010
2922
0.230
Why?
Acetamides
1
2023
20
0.230
Why?
Platelet Transfusion
2
2015
28
0.220
Why?
Humans
14
2023
50208
0.210
Why?
Aged
6
2017
9405
0.210
Why?
Antigens, CD34
2
2011
66
0.190
Why?
Cell Count
2
2011
149
0.190
Why?
Adult
6
2017
13324
0.180
Why?
Graft Survival
2
2011
150
0.180
Why?
Heart Rate
1
2021
298
0.180
Why?
Retrospective Studies
4
2017
6134
0.170
Why?
Cell Survival
2
2011
602
0.160
Why?
Liver Transplantation
1
2020
150
0.160
Why?
Incidence
1
2021
1006
0.160
Why?
Middle Aged
4
2017
12206
0.150
Why?
Cytomegalovirus Infections
1
2017
35
0.150
Why?
Transplantation, Homologous
1
2017
138
0.140
Why?
Appendicitis
1
2017
60
0.140
Why?
Regression Analysis
1
2017
395
0.140
Why?
Antineoplastic Agents, Alkylating
1
2016
74
0.140
Why?
Dendritic Cells
1
2016
133
0.130
Why?
Carmustine
1
2015
13
0.130
Why?
Postoperative Hemorrhage
1
2015
51
0.130
Why?
Cytarabine
1
2015
39
0.130
Why?
Etoposide
1
2015
72
0.130
Why?
Bronchoscopy
1
2015
70
0.130
Why?
Thrombocytopenia
1
2015
84
0.120
Why?
Survival Rate
1
2017
901
0.120
Why?
Salvage Therapy
1
2015
139
0.120
Why?
Drug Substitution
1
2014
9
0.120
Why?
Blood Cell Count
1
2014
38
0.120
Why?
Drug Evaluation
1
2014
28
0.120
Why?
Benzylamines
1
2014
15
0.120
Why?
Disease-Free Survival
1
2015
454
0.120
Why?
Heterocyclic Compounds
1
2014
29
0.120
Why?
Drug Synergism
1
2014
151
0.110
Why?
Risk Assessment
1
2017
1262
0.110
Why?
Nitriles
2
2023
54
0.100
Why?
Prognosis
1
2017
1954
0.100
Why?
Immune Tolerance
1
2011
95
0.100
Why?
Skin Neoplasms
1
2016
492
0.090
Why?
Dimethyl Sulfoxide
1
2010
12
0.090
Why?
Isotonic Solutions
1
2010
18
0.090
Why?
Pyrimidines
2
2023
193
0.090
Why?
P-Selectin
1
2010
32
0.090
Why?
Sodium Chloride
1
2010
58
0.090
Why?
Platelet Aggregation
1
2010
71
0.090
Why?
Platelet Activation
1
2010
47
0.090
Why?
Feasibility Studies
1
2011
380
0.090
Why?
Male
5
2017
25399
0.090
Why?
Hypersensitivity
1
2010
77
0.090
Why?
Female
4
2015
26635
0.080
Why?
Sensitivity and Specificity
1
2011
863
0.080
Why?
Atenolol
1
2008
14
0.080
Why?
Azetidines
1
2008
6
0.080
Why?
Amlodipine
1
2008
14
0.080
Why?
Hyperlipidemias
1
2008
50
0.080
Why?
Drug Interactions
1
2008
208
0.080
Why?
Young Adult
1
2017
3981
0.070
Why?
Antihypertensive Agents
1
2008
121
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
122
0.070
Why?
Aspirin
1
2008
114
0.070
Why?
Carcinoma, Non-Small-Cell Lung
1
2008
154
0.070
Why?
Coronary Artery Disease
1
2008
276
0.060
Why?
Neoplasm Recurrence, Local
1
2008
613
0.060
Why?
Hypertension
1
2008
537
0.050
Why?
Tomography, X-Ray Computed
1
2008
1161
0.050
Why?
Lung Neoplasms
1
2008
605
0.050
Why?
Chronic Disease
1
2023
571
0.050
Why?
Child
1
2011
6851
0.040
Why?
Ganciclovir
1
2017
24
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.030
Why?
Antiviral Agents
1
2017
173
0.030
Why?
Platelet Count
1
2015
72
0.030
Why?
Leukemia, Myeloid, Acute
1
2016
185
0.030
Why?
Bone Marrow
1
2016
363
0.030
Why?
Biopsy
1
2016
590
0.030
Why?
Practice Guidelines as Topic
1
2015
449
0.030
Why?
Antineoplastic Agents
1
2017
1186
0.020
Why?
Aged, 80 and over
1
2015
3154
0.020
Why?
Veeraputhiran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description